PTPA and cancer: As CMV promoter-driven expression of DN-PP2Acα induced cytotoxicity in both HCC cells and normal liver cells, cancer-specific delivery and/or gene expression are critical for the safety of gene therapy approaches which aim to inhibit PP2A.